Definitive Contract W81XWH21C0070
Award Date
5/7/21
Potential Completion Date
7/6/26
Potential Value
$4M
Federal Agency
Defense Health Agency
Awardee
Infrascan Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
AJ13 - General Science & Technology R&D Svcs; General Science & Technology; Experimental Development
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Philadelphia, PA 19104, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,761,139.00 definitive cost-no-fee contract awarded by the Defense Contract Management Agency (DCMA) to Infrascan Inc. for research and development. The contract has no set-aside designation and the ultimate completion date is May 25, 2019. Infrascan Inc. is a medical device company that specializes in developing handheld diagnostic devices for head injury and stroke assessment using near-infrared technology. This contract appears to be related to the company's work on portable...
This is a delivery order awarded to Infrascan Inc., a medical device company, by the U.S. Marine Corps under a larger contract vehicle. The award, worth $209,818.19, is for Other Direct Costs (ODC) related to the Small Business Innovation Research (SBIR) Program Phase III development of Infrascan's portable near-infrared technology to detect traumatic brain injuries. This technology has been the subject of prior SBIR Phase II and sole source contracts with the U.S. Army Medical Command and...
This is a $2,743,260.95 cost-plus-fixed-fee definitive contract awarded to Q30 Sports Science, LLC (doing business as Q30 Innovations) by the U.S. Army Medical Command for the development of a small wearable traumatic brain injury (TBI) prevention device. The contract has a period of performance through June 2, 2025, and does not have a set-aside designation. The contract originated from a U.S. Army Medical Research Acquisition Activity special notice for the sole-source procurement of...
The Department of the Army Medical Command awarded a $499,998.25 Definitive Contract to Hemosonics, LLC, a small business, to provide a point-of-care device for the diagnosis of platelet injury in trauma patients. This contract is part of the Small Business Innovation Research (SBIR) Program Phase II and is set aside for Total Small Businesses. Hemosonics, LLC specializes in providing medical equipment, particularly blood and hemostasis analyzers, to various government agencies, with the...
This is a firm fixed-price definitive contract awarded by the Defense Health Agency (DHA) to Ultradiagnostics Inc. for the development of a portable ultrasound system capable of transcranial imaging to assess traumatic brain injury (TBI). The contract, with a ceiling value of $4,503,258.06, was originally awarded on September 15, 2015 under the Joint Warfighter Medical Research Program (JWMRP) and had an initial period of performance through May 31, 2023. The contract is now being modified on...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Medical Command to Neurotheranostics Inc., a minority-owned small disadvantaged business. The contract, valued at $146,079.20, is for research to develop a point-of-injury therapy to maintain and stabilize moderate-to-severe traumatic brain injury (TBI). The contract is a firm-fixed-price definitive contract, with the work to be performed in Walled Lake, Michigan. This SBIR Phase I...
<p>This is a $2,000,000.00 fixed-price level of effort contract awarded by the Defense Health Agency (DHA) to Sense Diagnostics, Inc., a self-certified small disadvantaged business. The contract is for the SBIR Program Phase III action "DETECTION OF INTRACRANIAL" and has an ultimate completion date of October 31, 2024. The contract does not have a set-aside designation. This appears to be a follow-on award to prior federal contract and grant work performed by Sense Diagnostics.</p>
This is a federal contract award issued by the Defense Health Agency (DHA) to the Medical Technology Enterprise Consortium (MTEC), a non-profit organization that serves as a medical technology accelerator for the Department of Defense. The $1,340,612.39 award is for the "Development of a Fieldable Direct Osmotherapy Device for the Point-of-Injury Reduction of Cerebral Edema Following Penetrating Traumatic Brain Injury." This project aims to develop innovative medical products to...
This federal contract award is for a "BRAIN MACHINE INTERFACE PROTOTYPE" awarded by the U.S. Army Medical Command (MEDCOM) to the Medical Technology Enterprise Consortium (MTEC), a nonprofit organization that serves as a medical technology accelerator for the Department of Defense. The $4,394,911.28 contract, awarded on February 13, 2017, is an Other Transaction Order with no set-aside designation, indicating MTEC's broad-based approach to medical technology development. The...
This federal contract award was issued by the Research, Development and Engineering Command (RDECOM) of the Department of the Army to Advanced Brain Monitoring, Inc., a for-profit manufacturer of medical devices and equipment. The $87,609.92 firm fixed-price delivery order contract is for the provision of X24 B-ALERT EEG SYSTEM KITS and was placed under the company's existing Federal Supply Schedule (FSS) contract with the General Services Administration (GSA) for Medical Equipment and...